Molecular characterisation of the Her2-Top2A amplicon in breast cancer
MSc (Med), Faculty of Health Sciences, University of the Witwatersrand === The HER2 gene is amplified in 20-30% of breast cancers, a common cancer amongst South African women. HER2 amplification is associated with a poor prognosis and predicts response to treatments such as Herceptin. The gold sta...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10539/8737 |